See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

DHTV
Popular
Top Rated

Related Health Care Videos on Diabetes Health TV

Finding A Diabetes Educator Near You

Kim Higgins, CDE, RN

Finding A Diabetes Educator Near You

Diabetes Health and CVS Pharmacy

Special Coupon Savings Magazine

Diabetes Health and CVS Pharmacy

The Impact of Diabetes in Our Society

Jan Norman, RD, CDE

The Impact of Diabetes in Our Society

Health Care and Diabetes

Page 2
Diabetes Patients On Metformin Show Better Lipid Profile
Sep 10, 2014 | 
Chinese researchers found that type 2 diabetes patients taking metformin – one of the first lines of defense in the treatment of the disease - attained a better overall lipid profile compared with those who took glipizide.
Computerized Data Causes Some Patients To Lie To Protect Security, Study Finds
Sep 8, 2014 | 
Electronic health records might save time and paper, but some patients say they find themselves not being truthful when they see their physicians using them.
DHTV
Popular
Top Rated

Related Health Care Videos on Diabetes Health TV

Finding A Diabetes Educator Near You

Kim Higgins, CDE, RN

Finding A Diabetes Educator Near You

Diabetes Health and CVS Pharmacy

Special Coupon Savings Magazine

Diabetes Health and CVS Pharmacy

The Impact of Diabetes in Our Society

Jan Norman, RD, CDE

The Impact of Diabetes in Our Society

Study Shows New Wound Care Technology
Sep 6, 2014 | 
A new wound-care dressing developed by a California firm has been shown to not only reduce the cost of treating wounds, but also to improve the outcomes of those treatments.

That’s good news for diabetics. According to statistics, about 15 percent of those with the disease develop chronic wounds – most often foot ulcers – that can result in amputation.

The was study, conducted at the Southwest Regional Wound Care Center in Lubbock, Texas. They found, Enluxtra Any Wound dressing developed by OSNovative Systems, Inc., reduced medical costs of chronic wound care by 30 percent. In part because it replaces many different products. Including primary foam, the gelling agent alginate, hydrogel dressings, hydro-conductive fiber, super-absorbent collagen, opaque dressing, hydrocolloid, gauze and combination dressings.

Any Wound dressing, crafted of FDA-approved polymers, is designed to sense and accommodate the different parts of the wound that need hydration or absorption, and a single dressing can remain in place for up to seven days.
New Dual Artificial Pump- Still in Development
Sep 5, 2014 | 
Tandem is in partnership with the JDRF to develop a dual hormone pump which will continue to be funded, as Tandem reaches different milestones. Once approved by the FDA, this novel and groundbreaking medical device will have two hormone chambers. One chamber for insulin, the second chamber for a different hormone that supports different therapies. “At this time, insulin is the only approved hormone for an insulin pump,” says Susan Morrison, Chief Administrative Officer from Tandem Diabetes Care.
Alzheimer's New Name: Type 3 Diabetes
Sep 4, 2014 | 
When news about a startling new insight into the cause of Alzheimer's disease first emerged in 2005, it was highly speculative. But now the evidence for it has become very strong: Alzheimer's is a form of diabetes, and the name being given to it is type 3.
Genteel: A Pain Free Lancing Instrument
Aug 22, 2014 | 
All Dr. Christopher Jacobs’ friend wanted a lancing device that didn’t cause pain.  And after hearing the longtime type 1 diabetic lament the discomfort he felt from the many finger pricks required to test his blood glucose levels, Jacobs was intrigued by the challenge.
Dompé Earns Orphan Drug
Aug 20, 2014 | 
An Italian-based pharmaceutical company with subsidiaries in New York has been granted orphan drug status for a new drug to treat neurotrophic keratitis, a rare degenerative corneal disease that impacts less than 1 in 5,000 people worldwide.
Next Page » « Previous Page
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.